A Phase 1, Open-Label, 10 Day Safety Study

Clinical trial NCT01623401 · COMPLETED

Trial details

NCT number: NCT01623401
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2012-05-17
Primary completion: 2012-08-24
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.